These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10228661)

  • 21. [Homocysteinemia and vascular disease--a new risk factor is born].
    Reis RP; Luís AS
    Rev Port Cardiol; 1999 May; 18(5):507-14. PubMed ID: 10418265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Homocysteine, lipoprotein (a): risk factors for coronary heart disease].
    Laraqui A; Bennouar N; Meggouh F; Allami A; El Kadiri N; Benkouka F; Azeddoug H; El Haitem N; Benomar A; Fellat S; Benomar M
    Ann Biol Clin (Paris); 2002; 60(5):549-57. PubMed ID: 12368140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homocysteine: a new cardiac risk factor?
    Chai AU; Abrams J
    Clin Cardiol; 2001 Jan; 24(1):80-4. PubMed ID: 11195611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homocysteine and coronary artery disease.
    Futterman LG; Lemberg L
    Am J Crit Care; 1997 Jan; 6(1):72-7. PubMed ID: 9116791
    [No Abstract]   [Full Text] [Related]  

  • 25. Homocysteine. Is it a modifiable risk factor for patients with coronary artery disease?
    Por CP; Evans MF
    Can Fam Physician; 1998 Nov; 44():2409-11. PubMed ID: 9839058
    [No Abstract]   [Full Text] [Related]  

  • 26. [Homocysteine and cardiovascular risk].
    Auer J; Berent R; Weber T; Lassnig E; Eber B
    Wien Med Wochenschr; 2001; 151(1-2):25-8. PubMed ID: 11234594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Homocysteine and coronary artery disease].
    Aro A
    Duodecim; 2003; 119(12):1131-5. PubMed ID: 12868359
    [No Abstract]   [Full Text] [Related]  

  • 28. Hyperhomocysteinemia in liver transplant recipients: prevalence and multivariate analysis of predisposing factors.
    Herrero JI; Quiroga J; Sangro B; Beloqui O; Pardo F; Cienfuegos JA; Prieto J
    Liver Transpl; 2000 Sep; 6(5):614-8. PubMed ID: 10980061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homocysteine and coronary heart disease.
    Clarke R; Lewington S
    Semin Vasc Med; 2002 Nov; 2(4):391-9. PubMed ID: 16222629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
    Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Homocysteine as a coronary risk factor].
    Derbeneva SA; Pogozheva AV
    Vopr Pitan; 2003; 72(5):43-8. PubMed ID: 14619617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid.
    Kruger WD; Evans AA; Wang L; Malinow MR; Duell PB; Anderson PH; Block PC; Hess DL; Graf EE; Upson B
    Mol Genet Metab; 2000 May; 70(1):53-60. PubMed ID: 10833331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of homocysteine-lowering vitamin treatment on electrocardiography stress tests in a randomized, placebo-controlled trial: comparison between ST-segment changes and Athen QRS-score.
    Vermeulen EG; van Engeland MI; Visser FC; Stehouwer CD; Twisk JW; van Campen CM; Rauwerda JA
    Int J Cardiol; 2004 Feb; 93(2-3):323-4. PubMed ID: 14975573
    [No Abstract]   [Full Text] [Related]  

  • 34. Homocysteine, endothelial dysfunction, and coronary artery disease: emerging strategy for secondary prevention.
    Woo KS; Qiao M; Chook P; Poon PY; Chan AK; Lau JT; Fung KP; Woo JL
    J Card Surg; 2002; 17(5):432-5. PubMed ID: 12630544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Homocysteine--a risk factor for atherosclerosis].
    Debreceni L
    Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of vitamins B6, B12 and folic acid on hyperhomocysteinemia in a Pakistani population of patients with acute myocardial infarction.
    Iqbal MP; Ishaq M; Kazmi KA; Yousuf FA; Mehboobali N; Ali SA; Khan AH; Waqar MA
    Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):100-8. PubMed ID: 15871858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homocysteine, folates, and the eye.
    Wright AD; Martin N; Dodson PM
    Eye (Lond); 2008 Aug; 22(8):989-93. PubMed ID: 18064053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyperhomocysteinemia and advancement of atherosclerosis in patients with chronic renal failure on maintenance hemodialysis].
    Sydor A; Drozdz M; Kraśniak A; Miłkowski A; Chmiel G; Małczak J; Zabawa-Hołyś S; Moskal K; Podwysocki A; Szmigielski M; Czarnecka D; Gozdecka H; Kowalczyk-Michałek M; Szczeklik A; Wiecek A; Sułowicz W
    Przegl Lek; 2002; 59(12):962-7. PubMed ID: 12731367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for hyperhomocysteinemia in young adults with premature coronary artery disease.
    Cerone R; Minniti G; Piana A; Armani U; Susco G; Bertolini S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():148. PubMed ID: 11400754
    [No Abstract]   [Full Text] [Related]  

  • 40. Endpoints for homocysteine-lowering trials.
    Bostom AG; Garber C
    Lancet; 2000 Feb; 355(9203):511-2. PubMed ID: 10682995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.